Alpha-1 Antitrypsin Deficiency is a genetic disorder that can result in serious lung disease. This not-so-rare genetic disease is greatly underdiagnosed and is the most common known genetic risk factor for emphysema. Up to 3% of all people diagnosed with COPD may have undetected Alpha-1 Antitrypsin Deficiency. This presentation will provide the respiratory therapist with an appreciation of the disease, its prevalence, and its role in COPD as well as strategies for the respiratory therapist to assist in detection, education, and treatment of this population.

Presented by Robert Sandhaus MD, PhD, FCCP

This Live AARC webcast is approved for 1.0 CRCE

Seminar Objectives
  • Identify the prevalence of Alpha-1 Antitrypsin Deficiency
  • Explain the potential roles of the respiratory therapist in detection and testing for Alpha-1 Antitrypsin Deficiency
  • Evaluate the ways that a respiratory therapist can educate and help individuals with Alpha-1 Antitrypsin Deficiency live successfully and with improved quality of life
Seminar Information
Date Presented:
July 10, 2018 2:00 PM Eastern
Expiration Date:
October 01, 2018 12:00 AM
1 hour
Life/Honorary Price:
Member Price:
Senior Active Price:
Senior Associate Price:
Student Price:
WEB Sign-up Price:
Full Price:
Alpha-1 Antitrypsin Deficiency and the Respiratory Therapist: Test, Teach, and "Treat"
Individual topic purchase: Selected
American Association for Respiratory Care
Continuing Respiratory Care Education: 1.00